Australia purchases Pfizer vaccines from Poland as COVID-19 infections spike

United States News News

Australia purchases Pfizer vaccines from Poland as COVID-19 infections spike
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 97%

Australia has purchased about 1 million doses of Pfizer Inc's (PFE.N) COVID-19 vaccine from Poland to add to its inoculation efforts in Sydney and its home state, which on Saturday entered a snap lockdown amid record new infections.

Prime Minister Scott Morrison said on Sunday the extra vaccines would start arriving immediately and over half will be directed to 20- to 39-year-olds in New South Wales, as the state reported its second largest increase in locally transmitted infections. L4N2PL09M

"We've been seeing those case numbers rise in Sydney and New South Wales each day and that is terribly concerning," Morrison said at a news conference in Canberra. New South Wales, the most populous state, reported 415 new locally acquired cases of COVID-19 on Sunday, the second largest increase after the previous day's record 466.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster marketPfizer, Moderna seen reaping billions from COVID-19 vaccine booster marketDrugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say.
Read more »

Booster jabs are easy money for Pfizer and ModernaBooster jabs are easy money for Pfizer and ModernaThe U.S. has authorized a third dose of Covid-19 vaccines for people most at risk. That’s under 3% of the population, but broader use is likely in rich countries. Both producers will benefit, even if Moderna’s $160 bln valuation counts on more than just boosters in the future.
Read more »

Booster jabs are easy money for Pfizer and ModernaBooster jabs are easy money for Pfizer and ModernaModerna (MRNA.O) and Pfizer (PFE.N) just found an additional pot of gold. The U.S. Food and Drug Administration on Thursday authorized a third dose of their coronavirus vaccines for immunocompromised people. That’s about 3% of Americans, but broader use is probably coming soon. Both companies will benefit, but Moderna’s roughly $160 billion market capitalization depends on it more.
Read more »

Thomas Doherty Got COVID Right Before His Planned VaccinationThomas Doherty Got COVID Right Before His Planned VaccinationGossipGirl star Thomas Doherty admits he initially put off getting the CovidVaccine because he was nervous about possible side effects.
Read more »

Protest Outside Los Angeles City Hall Leaves One Person StabbedProtest Outside Los Angeles City Hall Leaves One Person StabbedA group of people converged on Saturday to protest vaccine mandates related to COVID-19.
Read more »

Pfizer, Moderna seen reaping billions from COVID-19 vaccine booster marketPfizer, Moderna seen reaping billions from COVID-19 vaccine booster marketDrugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6 billion in annual sales for flu vaccines for years to come, analysts and healthcare investors say.
Read more »



Render Time: 2025-02-26 13:09:34